A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection.
Julia HessKristian UngerCornelius MaihoeferLars SchüttrumpfLudmila WintergerstTheresa HeiderPeter WeberSebastian MarschnerHerbert BraselmannDaniel SamagaSebastian KugerUlrike PflugradtPhilipp BaumeisterAxel WalchChristine WoischkeThomas KirchnerMartin WernerKristin WernerMichael BaumannVolker BudachStephanie E CombsJürgen DebusAnca-Ligia GrosuMechthild KrauseAnnett LingeClaus RödelMartin StuschkeDaniel ZipsHorst ZitzelsbergerUte GanswindtMichael HenkeClaus BelkaPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)
The five-miRNA signature is a strong and independent prognostic factor for disease recurrence and survival of patients with HPV-negative HNSCC.See related commentary by Clump et al., p. 1441.